Auszug
Die Knochenszintigraphie zählt seit über 40 Jahren zu den häufigsten Untersuchungen in der Nuklearmedizin, auch wenn zugestanden wird, dass CT und v. a. MRT zu einer Reduktion der Nachfrage beigetragen haben [s. Literatur auf ➭ 10.1]. Durch die Entwicklung von SPECT gab es eine gewisse Gegenbewegung: Knochentumore, Fieber unklarer Genese, infektiöse und inf lam matorische Erkrankungen, deren Ursache anderweitig nicht abklärbar ist, sind Indikationsspektrum der Szintigraphie mit 99mTc-markierten Antigranulozyten-Antikörpern (Immunszintigraphie) [➭ 10.2].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Abella HA (2005) Report-Musculoskeletal. diagnosticimaging. com. Diagn Imag Eur 3:35–37
Adams S, Hör G (2004) Nuklearmedizinische Diagnostik von Knochenentzündungen. In Schnettler R, Steinau HU (Hrsg) Septische Knochenchirurgie. Thieme, Stuttgart, S 57–74
Berger F, Lee YP, Loening AM et al. (2002) Whole body skeletal imaging in mice utilizing micro-PET: optimization of reproducibility and applications in animal models of bone disease. Eur J Nucl Med Mol Imaging 29:1225–1236
Brenner W, Conrad EU, Eary JF (2004) FDG PET imaging for grading and prediction of outcome in chrondrosarcoma patients. Eur J Nucl Med Mol Imaging 31:189–195
Brenner W, Vernon Ch, Muzi M et al. (2004) Comparison of different quantitative approaches to 18 F-Fluoride PET scans. J Nucl Med 45:1493–1500
Cremerius U, Mumme T, Reinartz P et al. (2003) Analyse des 18 F-FDG Speichermusters in der PET zur Diagnostik von septischer und aseptischer Lockerung bei Totalendoprothesen des Hüftgelenks. Nuklearmedizin 42:234–239
Even-Sapir E (2005) Imaging of malignant bone involvement by morphological, scintigraphic and hybrid modalities. J Nucl Med 46:1356–67
Even-Sapir E, Metser U, Flusser G et al. (2004) Assessment of malignant skeletal disease:Initial experience with 18F-fluoride PET and 18 F-fluoride PET/CT. J Nucl Med 45:272–278
Folpe AL, Lyles RH, Sprouse JT et al. (2000) (F-18) fluordeoxyglucose positron emission tomography as a predictor of pathological grade and other prognostic variables in bone and soft tissue sarcoma. Clin Cancer Res 6:12379–87
Francius C, Sciuk J (2000) Positronenemissionstomographie mit F-18-Fluordesoxyglukose (FDG PET)im Kindes-und Jugendalter (Erfahrungen an über 500 pädiatrischen Patienten). Der Nuklearmediziner 23:287–295
Francius C, Bielack S, Flege S et al. (2002) Prognostic significance of 18 F-FDG and 99mTc-methylene diphosphonate uptake in primary osteosarcoma. J Nucl Med 43:1012–1017
Francius C, Daldrup-Link HE, Sciuk J et al. (2001) FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: Comparison with spiral CT. Ann Oncol 12:479–486
Francius C, Daldrup-Link HE, Wagner-Bohn A et al. (2002) FDG-PET for detection of recurrences from malignant primary bone tumors: comparison with conventional imaging. Ann Oncol 13:157–160
Francius C, Sciuk J, Brinkschmidt C et al. (2000) Evaluation of chemotherapy response in primary bone tumors with F-18 FDG positron emission tomography compared with histologically assessed tumor necrosis. Clin Nucl Med 25:874–881
Francius C, Sciuk J, Daldrup-Link HE et al. (2000) FDG-PET for detection of osseous metastases from malignant primary bone tumours:comparison with bone scintigraphy. Eur J Nucl Med 27:1305–1311
Hoegerle S, Juengling F, Otte A et al. (1998) Combined FDG and F-18-fluoride whole body PET: a feasible two-in-oneapproach to cancer imaging. Radiology 209:253–258
Piert M, Winter E, Becker GA, Bilger K et al. (1999) Allogenic bone graft viability after hip revision arthroplasty assessed by dynamic (18 F)fluoride ion positron emission tomography. Eur J Nucl Med 26:615–624
Sasaki M, Ichiya Y, Kuwabara Y, Otsuka M, Fukumura T, Kawai Y, Koga H, Masuda K (1993) Fluorine-18-fluorodeoxyglucose positron emission tomography in technetium-99 m-hydroxymethylenediphosphate negative bone tumors. J Nucl Med 34:288–290
Schirrmeister H, Glatting G, Hetzel J et al. (2001) Prospective evaluation of the clinical value of planar bone scans, SPECT, and 18F-labeled NAF PET in newly diagnosed lung cancer. J Nucl Med 42:1800–1804
Zhuang H, Duarte PS, Pourdehnad M et al. (2001) The promising role of 18F-FDG PET in detecting infected lower limb prosthesis implants. J Nucl Med 42:44–48
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
(2006). Onkologische Orthopädie. In: PET/CT-Atlas. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-31215-3_10
Download citation
DOI: https://doi.org/10.1007/3-540-31215-3_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-31214-7
Online ISBN: 978-3-540-31215-4
eBook Packages: Medicine (German Language)